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Available online 4 June 2016Background: The prevalence of morbidly adherent placenta has dramatically increased in the setting of the rising
cesarean rate in the United States. Delayed surgical management of placenta accreta and its variants is emerging
asmethods that may signiﬁcantly decrease bleeding and perioperative complications; however, optimal surgical
approaches have not yet been determined. In this report, we present a case of robotic-assisted delayed interval
hysterectomy in a patient with placenta percreta.
Method: Aminimally invasive approach, via a robotic-assisted total laparoscopic hysterectomy, was utilized for a
39-year-old gravida 9 para 3 with placenta percreta with placenta left in situ ten weeks after a tertiary cesarean
section.
Experience: The robotic approach provided excellent visualization to facilitate ﬁne planes of dissection, lower
than expected estimated blood loss, and faster recover times when compared with conventional surgical ap-
proaches traditionally utilized for interval hysterectomies for placenta percreta.
Conclusion: Robotic-assisted hysterectomymay be considered as an alternative to laparotomy for the delayed in-
terval surgical management of morbidly adherent placenta percreta.








As the rate of cesarean section in the United States has increased
from under 5% in the 1960s to over 30% in 2002, abnormal placentation
has dramatically risen in parallel (Wu et al., 2005; Martin et al., 2015).
The incidence of placenta accreta, deﬁned as an abnormal attachment
of the placenta to the myometrium, is now suspected to occur with
1:533 deliveries (Wu et al., 2005). More severe variants of abnormal
placentation include placenta increta, in which placental villi invade
into themyometrium, and placenta percreta, in which placental villi in-
vade through the myometrium. In cases of placenta percreta, the blad-
der is the most common attachment site outside of the uterus (Perez-
Delboy and Wright, 2014). These disorders, characterized as morbidly
adherent placenta (MAP), are associated with high risk of maternal
morbidity from large volume blood loss, need for transfusion, intra-
abdominal infections, ureteral damage, and ﬁstula formation, as well
as maternal mortality rates estimated as high as 7% (Sentilhes et al.,
2010).cs and Gynecology, Columbia
ashington Ave., 8th Floor, New
rke).
. This is an open access article underSeverematernalmorbidity andmortality fromMAP stem almost en-
tirely from hemorrhage-related complications. Median estimated blood
loss at time of cesarean hysterectomy for patients with placenta accreta
has been reported to be 3 l with a mean transfusion requirement of
5 units of packed red blood cells (Wright et al., 2011). In addition to
higher estimated blood loss, placenta percreta places patients at higher
risk of bladder and ureteral injury (Sentilhes et al., 2010). In patients
with placenta percreta, conservative management in which the uterus
and the placenta are left in situ at time of cesarean delivery has been
shown to decrease blood loss, need for transfusion, and disseminated
intravascular coagulation through placental involution (Perez-Delboy
and Wright, 2014; Wright et al., 2011). Despite limited literature on
the best time for a delayed hysterectomy, to maximize the decrease in
placental volume seen after embolization, the interval procedure is typ-
ically scheduled 6 to 8 weeks after delivery. Though in rare cases the
placenta involutes and is passed vaginally, the vast majority of patients
require a second surgery. In these patients, the delayed hysterectomy is
routinely via laparotomy.
2. Method
Minimally invasive approaches for interval hysterectomy in patients
with MAP have not been well studied despite lower rates of complica-
tions, lower blood loss, and shorter hospital stays for laparoscopythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Placenta seen on the anterior surface of the uterus.
54 D.M. Rupley et al. / Gynecologic Oncology Reports 17 (2016) 53–55when compared to laparotomy. A small number of case reports describe
additional beneﬁts of laparoscopic assisted vaginal hysterectomy for
placenta percreta including better visualization allowing for superior
dissection of the bladder and improved hemostasis attributable to
pneumoperitoneum (Wright et al., 2011). Robotic assisted laparoscopic
hysterectomy has previously been described in a patient with placenta
increta following delivery of a 20-week fetus in the setting of preterm
premature rupture of membranes (Boes et al., 2013). Here, we present
a patient who underwent a delayed interval robotic-assisted total lapa-
roscopic hysterectomy for placenta percreta. Steps are detailed in oper-
ative video.
3. Experience
A 39-year-old gravida 9 para 3 with a surgical history notable for 2
prior low transverse cesarean deliveries and 5 prior dilation and curet-
tage procedures was diagnosed prenatally by an ultrasound at
32+5weeks gestation that showed placenta accreta, possible percreta.
Her past medical history was uncomplicated. The pelvic ultrasound
showed obliteration of the uterine interface, loss of the hypoechoic
retroplacental zone, and increased vascularity proximal to the bladder,
concerning for abnormal placentation. She subsequently underwent a
pelvic MRI at 33 + 3 weeks that demonstrated loss of the myometrial
margin and a placental lobule seen along the superior urinary bladder
surface consistent with placenta accreta, and concerning for possible
percreta. The patient was admitted to the hospital at 35+ 2weeks ges-
tation in preparation for a scheduled tertiary cesarean section via amid-
line vertical incision, fundal hysterotomy, uterine artery embolization
and delayed hysterectomy. The patient was also consented for the pos-
sibility of an immediate hysterectomy in the event of uncontrollable
bleeding. Prior to surgery at 35 + 6 weeks, she underwent placement
of hypogastric artery balloon catheters and bilateral ureteral stents. Pre-
operative cystoscopy was performed, showing a mass effect on the su-
perior aspect of the dome of the bladder. Her cesarean section was
notable for suspected placenta percreta on both the left anterior surface
of the uterus above the bladder reﬂection and invasionof tortuous blood
vessels on the uterine serosa into the right broad ligament. Given these
ﬁndings and extensive pre-operative counseling, in hope of decreasing
the likelihood of bladder injury, blood loss, and need for ureteral re-
implantation, the placentawas left in-situ and a 3150 g neonatewas de-
livered via fundal hysterotomywith Apgars of 1, 5, and 9. The umbilical
cord was ligated, the placenta left in situ, and the hysterotomy was
closed in the usual fashion. The patient then underwent embolization
of her uterine arteries, and the ureteral stents were removed. Total esti-
mated blood loss for the case was 1 l.
The patient received 2 units of packed red cells for symptomatic ane-
mia on post-operative day 1. She recovered well and was discharged
home with a plan for interval hysterectomy between 6 and 8 weeks.
At the time of planned interval hysterectomy, the patient declined sur-
gery despite intensive counseling, stating she was not physically or
emotionally ready for a second surgery. She was lost to follow-up and
re-presented to the emergency department 9 + 4 weeks from her ce-
sarean section with complaints of vaginal bleeding. On physical exam,
vaginal bleeding was minimal and her vital signs were within normal
limits. She was admitted to the hospital and underwent a pelvic MRI
which was notable for an enlarged uterus, with preserved fat plane be-
tween the bladder and the uterus and no evidence of periuterine exten-
sion of the placenta or bladder invasion.
Given her stable condition and her surgical history, she was
counseled on the risks and beneﬁts of various surgical options of man-
agement including open and minimally invasive approaches, and she
opted to proceed with minimally invasive hysterectomy. She was
taken to the operating room ten weeks after her cesarean section. She
was given 2 g intravenous cefazolin for antibiotic prophylaxis, posi-
tioned in dorsal lithotomy, ureteral stents were placed, and an
Advincula Arch uterine manipulator with a KOH cup was inserted. Thesurgical system was docked in the center position after ports were
placed in the typical fashion to allow for the completion of a radical hys-
terectomy. Surgical instrumentation used in this case included the
monopolar shears, the PK™ dissecting forceps, and the prograsp
forceps.
On survey of the abdomen, the lower uterine segment was bulging
with the bladder densely adhered to the anterior portion of the placenta
(Fig. 1). The hysterectomy (see video)was started by opening the pelvic
sidewall lateral and parallel to the infundibulopelvic ligament. Limited
collateral blood vessel formation was noted in the pelvis. The utero-
ovarian ligaments were identiﬁed and dissected. The uterine arteries
were skeletonized and sealed at their origin for added hemostasis. Fol-
lowing careful dissection of the bladder from the anterior uterus, the
placenta was noted to be bulging, obscuring visual and tactile localiza-
tion of the KOH cup anteriorly. Thus, colpotomywas initiated posterior-
ly. Once the posterior colpotomywas completed, careful dissection was
undertaken to facilitate the anterior colpotomy. The uterus was placed
in a 15 cm endocatch bag and removed vaginally through contained
in-bag morcellation. Hemostasis was assured and the vaginal cuff was
closed in the usual fashion. The estimated blood losswas 400ml and op-
erative time was 3 h and 10 min. Post-operatively, the patient received
2 units of packed red cells for symptomatic anemia. Shewas discharged
home on post-operative day 3 in excellent condition. Pathology
returned consistent with placenta percreta with the myometrium
showing marked degeneration and hyalinization (Fig. 2).
4. Discussion
This case report of a patientwithmorbidly adherent placenta treated
with an interval robotic-assisted hysterectomy ten weeks post-partum
demonstrates that a minimally invasive robotic surgical approach is a
feasible option for management of select patients with morbidly adher-
ent placenta. Though there may be variations on how to complete this
procedure robotically, our recommendation is to approach these cases
with a docking style and instrumentation selection that is typically uti-
lized for radical hysterectomy.
Hysterectomies performed for placenta accreta, increta, and percreta
are high-risk procedures associated with substantial maternal morbidi-
ty and mortality, largely attributed to the high blood loss. Additionally,
patients with placenta percreta and subsequent invasion of the placenta
near or into the bladder are at dramatically increased risk of intraoper-
ative bladder or ureteral injury. Use of robotic-assisted total laparoscop-
ic hysterectomy in select patients can decrease both blood loss and rates
of bladder injury through improved visualization and surgical precision.
Patients also beneﬁt from the well-established advantages of minimally
invasive procedures, including decreased post-operative pain, shorter
hospital stay, and faster recovery.
Fig. 2. Pathology demonstrating placenta percreta.
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invasive approaches for hysterectomy for morbidly adherent placenta.
Patients should be followed closely in the outpatient setting with regu-
lar ultrasounds and MRI to deﬁne extent of uterine invasion. Many pa-
tients with morbidly adherent placenta pathology require emergent
surgical interventions, which precludes a robotic approach. The patient
described in this report underwent post-cesarean section uterine artery
embolization, allowing for decreased vascularization of the uterusduring her hysterectomy. This approach requires coordinated, multidis-
ciplinary pre-surgical planning, which may only be possible at tertiary
care centers. In addition, operative teamsmust be experienced with ro-
botic surgery, blood products should be readily available, and teams
must be ready to convert to open laparotomy in case of emergency.
The increasing incidence and the associated severe morbidity and
mortality of morbidly adherent placenta in the United States make
this an urgent issue of study. Determination of optimal surgical ap-
proaches, including robotic approaches for management of placenta
accreta, increta, and percreta, is essential to decreasing maternal mor-
bidity and mortality from this increasingly common disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gore.2016.05.009.
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